Skip to content

Test-retest reliability, discriminative ability and validity of the Mobility Monitor and test-retest reliability of the Q-force

Test-retest reliability, discriminative ability and validity of the Mobility Monitor and test-retest reliability of the Q-force - Psychometric properties of the Mobility Monitor and the Q-force

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36105
Enrollment
50
Registered
2011-06-23
Start date
2011-10-21
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy older adults Not applicable.

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Community-dwelling older persons aged 70 years or older. - Older persons who can perform STS transfers with the arms crossed on the chest. - Older persons who can walk 10 meter without using a walking aid (such as a cane or rollator).

Exclusion criteria

Exclusion criteria: - Cognitive impairment or other neurologic diseases that can impair STS transfers, walking or understanding instructions. - Severe co-morbidity. - Not being able to read and understand Dutch instructions. - Total hip replacement surgery in the previous 6 months. - Visual problems to a degree that makes it impossible for the subject to accurately read or walk and stand up safely. - Having had a stroke within the last 6 months. - Parkinson*s disease stage 4 or 5.

Design outcomes

Primary

MeasureTime frame
The main study parameters are test-retest reliability, disriminative ability and convergent validity of STS power assessment of the Mobility Monitor and of 3D hybrid motion sensors, and test-retest reliability of strength measurement of the Q-force.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)